European Commission Approves Subcutaneous Formulation of Entyvio® (Vedolizumab) for use as Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease
Find out How Prime Healers are Helping Patients Getting Treated at Home Amid Lock Down
Rimini Street Announces Fiscal First Quarter 2020 Financial Results
Amazon Original Series Regular Heroes to Premiere May 8 Highlighting Courageous Stories From the Front-Lines of COVID-19
Andersen Global Strengthens Eastern Europe Presence; Debuts in Ukraine
Esri Offers Free Access to GIS Training for Furloughed Professionals Affected by Coronavirus